Vehicle opthalmic solution

DRUG2 trials

Sponsors

Sylentis, S.A., Aldeyra Therapeutics, Inc.

Conditions

Dry EyeDry Eye DiseaseDry Eye Syndromes

Phase 2

The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease

CompletedNCT04674358

Aldeyra Therapeutics, Inc.Dry Eye, Dry Eye Syndromes

Start: 2020-11-21End: 2021-09-12Updated: 2025-03-19

Phase 3

HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)

CompletedNCT03108664

Sylentis, S.A.Dry Eye Disease

Start: 2017-05-18End: 2018-11-16Updated: 2019-02-15